{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T06:18:29Z","timestamp":1725776309849},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1988,1,1]],"date-time":"1988-01-01T00:00:00Z","timestamp":567993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1988]]},"DOI":"10.1007\/bf00542485","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T04:40:47Z","timestamp":1100839247000},"page":"549-555","source":"Crossref","is-referenced-by-count":3,"title":["Sustained release verapamil in renal hypertension"],"prefix":"10.1007","volume":"33","author":[{"given":"H.","family":"Eiskj\ufffdr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. B.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/01.HYP.7.5.688","volume":"5","author":"G Berglund","year":"1985","unstructured":"Berglund G, De Faire U, Castenfors J, Andersson G, Hartford M, Liedholm H, Ljungman S, Thulin T, Wikstrand J (1985) Monitoring 24-hour blood pressure in a drug trial. Evaluation of a noninvasive device. Hypertension 5: 688?694","journal-title":"Hypertension"},{"key":"CR2","volume-title":"Ciba Symposium-Antihypertensive therapy: Principles and practice","author":"KD Bock","year":"1966","unstructured":"Bock KD, Kreuzenbeck W (1966) Spontaneous blood pressure variations in hypertension: The effect of antihypertensive therapy and correlations with the incidence of complications. In: Gross E (ed) Ciba Symposium-Antihypertensive therapy: Principles and practice. Springer-Verlag, Berlin Heidelberg New York"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000183918","volume":"44","author":"R Boero","year":"1986","unstructured":"Boero R, Quarello F, Guarena C, Piccoli G (1986) Verapamil in arterial hypertension with renal disease. Nephron 44: 80","journal-title":"Nephron"},{"key":"CR4","volume-title":"Distribution-free statistical tests","author":"JV Bradley","year":"1968","unstructured":"Bradley JV (1968) Distribution-free statistical tests. Prentice-Hall, Englewood Cliffs, NJ, USA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/cs0640141","volume":"64","author":"J Brod","year":"1983","unstructured":"Brod J, Bahlmann J, Cachovan M, Pretschner P (1983) Development of hypertension in renal failure. Clin Sci 64: 141?152","journal-title":"Clin Sci"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0021-9150(81)90014-9","volume":"39","author":"LA Carlson","year":"1981","unstructured":"Carlson LA, B\u00f6ttiger LE (1981) Serum triglycerides, to be or not to be a risk factor for ischemic heart disease? Atherosclerosis 39: 287","journal-title":"Atherosclerosis"},{"key":"CR7","volume-title":"Renal disease. Classification and atlas of glomerular disease","author":"J Churg","year":"1982","unstructured":"Churg J (1982) Renal disease. Classification and atlas of glomerular disease. Igahu-Schoen, Tokyo"},{"key":"CR8","first-page":"507","volume":"74","author":"D Edmonds","year":"1985","unstructured":"Edmonds D, Baumgart P, Tenschert W, Vetter W, Vetter H (1985) Verapamil 240 mg ? effective blood pressure reduction with a single daily dose? Schweiz Rundsch Med Prax 74: 507?509","journal-title":"Schweiz Rundsch Med Prax"},{"issue":"Suppl","key":"CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0954-6820.1984.tb08677.x","volume":"681","author":"O F\u00e6rgeman","year":"1984","unstructured":"F\u00e6rgeman O, Meinertz H, Hansen JF (1984) Serum lipoproteins after treatment with verapamil for 6 months. Acta Med Scand 681 [Suppl]: 49?51","journal-title":"Acta Med Scand"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","volume":"62","author":"T Gordon","year":"1977","unstructured":"Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62: 707?713","journal-title":"Am J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-94-1-7","volume":"94","author":"RH Grimm","year":"1981","unstructured":"Grimm RH, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H (1981) Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Intern Med 94: 7?11","journal-title":"Ann Intern Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/clpt.1981.72","volume":"29","author":"JH Hull","year":"1981","unstructured":"Hull JH, Hak LJ, Koch GG, Wargin WA, Chi SL, Mattocks AM (1981) Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther 29: 516?521","journal-title":"Clin Pharmacol Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.0954-6820.1982.tb01980.x","volume":"211","author":"HJ J\u00fcrgensen","year":"1982","unstructured":"J\u00fcrgensen HJ, Meinertz H, F\u00e6rgeman O (1982) Plasma lipids and lipoproteins in long term beta-adrenergic blockade. Acta Med Scand 211: 449?452","journal-title":"Acta Med Scand"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0009-8981(76)90338-7","volume":"67","author":"AM Kappelgaard","year":"1976","unstructured":"Kappelgaard AM, Nielsen MD, Giese J (1976) Measurement of angiotensin II in human plasma: Technical modifications and practical experience. Clin Chim Acta 67: 299?306","journal-title":"Clin Chim Acta"},{"key":"CR15","unstructured":"Kerr DNS (1982) The assessment of renal function. Medical Education (International) Ltd.: 1049?1053"},{"key":"CR16","first-page":"351","volume":"87","author":"GRJ Lewis","year":"1978","unstructured":"Lewis GRJ, Morley KD, Lewis BM (1978) The treatment of hypertension with verapamil. N Z Med J 87: 351","journal-title":"N Z Med J"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"375S","DOI":"10.1042\/cs057375s","volume":"57","author":"S Mann","year":"1979","unstructured":"Mann S, Millar Craig MW, Altman DG, Melville DI, Raftery EB (1979) The effects of metoprolol on ambulatory blood pressure. Clin Sci 57: 375S-377S","journal-title":"Clin Sci"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/00365518609083700","volume":"46","author":"A M\u00f8ller","year":"1986","unstructured":"M\u00f8ller A, Rasmussen L, Ledet T, Christiansen JS, Christensen CK, Mogensen CE, Hermansen K (1986) Lipoprotein changes during continuous subcutaneous insulin infusion in insulin-dependent diabetic patients. Scand J Clin Lab Invest 46: 471?475","journal-title":"Scand J Clin Lab Invest"},{"key":"CR19","first-page":"365","volume":"7","author":"JL Palma","year":"1985","unstructured":"Palma JL, Codina J (1985) Ambulatory monitoring of blood pressure and arrhythmias by noninvasive methods in hypertensive patients treated with metoprolol. Clin Exp Hxypertens 7: 365?369","journal-title":"Clin Exp Hxypertens"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00543482","volume":"26","author":"EB Pedersen","year":"1984","unstructured":"Pedersen EB, Danielsen H, Spencer ES (1984) Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 26: 543?547","journal-title":"Eur J Clin Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00606677","volume":"13","author":"OL Pedersen","year":"1978","unstructured":"Pedersen OL (1978) Does verapamil have a significant antihypertensive effect? Eur J Clin Pharmacol 13: 21","journal-title":"Eur J Clin Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(85)90351-4","volume":"2","author":"W Rascher","year":"1985","unstructured":"Rascher W, Tulassay T, Lang RE (1985) Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet 2: 303?305","journal-title":"Lancet"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/00365521.1974.12096851","volume":"9","author":"J Rask-Madsen","year":"1974","unstructured":"Rask-Madsen J, Bruunsgaard A, Munck O, Nielsen MD, Worning H (1974) The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 9: 417?426","journal-title":"Scand J Gastroenterol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00004872-198504000-00005","volume":"3","author":"F Rion","year":"1985","unstructured":"Rion F, Waeber B, Graf HJ, Jaussi A, Porchet M, Brunner HR (1985) Blood pressure response to antihypertensive therapy: Ambulatory versus office blood pressure readings. J Hypertension 3: 139?143","journal-title":"J Hypertension"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","volume":"52","author":"GL Robertson","year":"1973","unstructured":"Robertson GL, Mahr EA, Athar S, Sinna T (1973) Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52: 2340?2353","journal-title":"J Clin Invest"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00544077","volume":"29","author":"SS S\u00f8rensen","year":"1985","unstructured":"S\u00f8rensen SS, Thomson O\u00d8, Danielsen H, Pedersen EB (1985) Effect of verapamil on renal plasma flow, glomerular filtration rate and plasma angiotensin II, aldosterone and arginine vasopressin in essential hypertension. Eur J Clin Pharmacol 29: 257?261","journal-title":"Eur J Clin Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0167-5273(87)90075-1","volume":"17","author":"AR Thomassen","year":"1987","unstructured":"Thomassen AR, Bagger JP, Nielsen TT, Pedersen EB (1987) Atrial natriuretic peptide during pacing in controls and patients with coronary artery disease. Int J Cardiol 17: 267?276","journal-title":"Int J Cardiol"},{"issue":"Suppl","key":"CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.0954-6820.1984.tb08676.x","volume":"681","author":"G Walldius","year":"1984","unstructured":"Walldius G (1984) Effect of verapamil on serum lipoproteins in patients with angina pectoris. Acta Med Scand 681 [Suppl]: 43?48","journal-title":"Acta Med Scand"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/cs0710157","volume":"71","author":"MR Wilkins","year":"1986","unstructured":"Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J (1986) Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci 71: 157?160","journal-title":"Clin Sci"},{"key":"CR30","first-page":"307","volume":"16","author":"R Wilkinson","year":"1981","unstructured":"Wilkinson R, Sellars L, Pickering M, Robson V, Kerr DNS (1981) The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol. Clin Nephrol 16: 307?313","journal-title":"Clin Nephrol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"74D","DOI":"10.1016\/0002-9149(86)90811-8","volume":"57","author":"PK Zachariah","year":"1986","unstructured":"Zachariah PK, Sheps SG, Schirger A, Spiekerman RE, O'Brien P, Simpson KK (1986) Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension. Am J Cardiol 57: 74D-79D","journal-title":"Am J Cardiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00542485\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T15:33:40Z","timestamp":1705332820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00542485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1988]]}},"alternative-id":["BF00542485"],"URL":"https:\/\/doi.org\/10.1007\/bf00542485","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988]]}}}